Boji Medical Technology Co., Ltd Boji Medical Technology Co., Ltd
EN
CN EN
OA系统
   

One-stop, Full-process
CRO+CDMO Flagship Service Provider
   
    十载芳华 向光而行

BOJIMED

Boji Medical Technology Co., Ltd. was founded in 2002 and listed on the Shenzhen Stock Exchange in 2015. As a leading Contract Research Organization (CRO), it specializes in providing innovative drug R&D and manufacturing services with a one-stop, full-process solution for pharmaceutical companies worldwide.

  • 1500+

    Number of employees

  • 2000+

    Number of customers

  • 4000+

    Number of projects

  • 900+

    Partner Organizations

More

Business Introduction

Clinical Research Services
01
Clinical Research Services
01
Clinical Research Services
Comprehensive support spanning clinical trial protocol design, project management, data statistics, and analysis, enabling the safe and effective clinical validation of drugs...
Preclinical Research Services
02
Preclinical Research Services
02
Preclinical Research Services
Conduct pharmacodynamic, pharmacokinetic, and toxicological studies to establish a foundation for candidate drug screening and optimization, thereby reducing R&D risks...
Full-chain Services for Traditional Chinese Medicine R&D
03
Full-chain Services for Traditional Chinese Medicine R&D
03
Full-chain Services for Traditional Chinese Medicine R&D
From herbal extraction and process development to quality standard formulation and clinical trial applications, covering every stage of traditional Chinese medicine research and development...
Overseas R&D Operations
04
Overseas R&D Operations
04
Overseas R&D Operations
Aligning with international regulatory requirements, we provide overseas clinical trial planning, application submission, and project execution services to advance the global expansion of pharmaceutical products...
Therapeutic Areas
05
Therapeutic Areas
05
Therapeutic Areas
Focusing on multiple disease areas including oncology, anti-infectives (hepatology), cardiovascular, neurology, and endocrinology, we provide specialized R&D solutions...
Ongoing Project Transfer
06
Ongoing Project Transfer
06
Ongoing Project Transfer
Integrate high-quality pipeline resources, provide project transfer and collaboration opportunities, and accelerate the commercialization of R&D outcomes...

BOJI VIEW

Wu Caimei, Deputy General Manager of Xinglin Traditional Chinese Medicine, a subsidiary of Bozhi Medicine, published a signed article in "Pharmaceutical Economic News"
2025-12-16
Wu Caimei, Deputy General Manager of Xinglin Traditional Chinese Medicine, a subsidiary of Bozhi Medicine, published a signed article in "Pharmaceutical Economic News"
Innovation Discussed at the Foot of Changbai Mountain, a New Journey of Traditional Chinese Medicine R&D Initiated - "BoJi New Drug Talk" Traditional Chinese Medicine R&D Salon Successfully Held in Changchun!
2025-12-15
Innovation Discussed at the Foot of Changbai Mountain, a New Journey of Traditional Chinese Medicine R&D Initiated - "BoJi New Drug Talk" Traditional Chinese Medicine R&D Salon Successfully Held in Changchun!
BoJi Medicine appeared at the 2025 Changchun International Pharmaceutical and Health Industry Expo to explore new industrial opportunities together!
2025-12-10
BoJi Medicine appeared at the 2025 Changchun International Pharmaceutical and Health Industry Expo to explore new industrial opportunities together!
  • Good news! The drug formulation technology independently developed by BOCHEM has been granted an invention patent.
    2025.12.09
  • Deepening Industry-Academia-Research Integration to Jointly Cultivate Pharmaceutical Talents —— Shenyang Pharmaceutical University and Boji Medical Series of Collaboration Events Successfully Concluded
    2025.12.08
  • [Boji Assistance] SA1211 injection, a new drug for hepatitis B independently developed by Shi'an Biotechnology, has successfully completed the first administration
    2025.11.28

Previous :

Next :

Close